ProQR Therapeutics EBITDA 2015-2019 | PRQR

ProQR Therapeutics ebitda from 2015 to 2019. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
ProQR Therapeutics Annual EBITDA
(Millions of US $)
2018 $-42
2017 $-45
2016 $-42
2015 $-29
2014 $-22
2013 $0
ProQR Therapeutics Quarterly EBITDA
(Millions of US $)
Q2 2019 $-13
Q1 2019 $-16
Q4 2018 $-14
Q3 2018 $-7
Q2 2018 $-9
Q1 2018 $-12
Q4 2017 $-12
Q3 2017 $-11
Q2 2017 $-11
Q1 2017 $-10
Q4 2016 $-11
Q3 2016 $-11
Q2 2016 $-12
Q1 2016 $-9
Q4 2015 $-6
Q3 2015 $-8
Q2 2015 $-8
Q1 2015 $-8
Q4 2014 $0
Q3 2014 $-6
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.276B $0.000B
ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.224B 13.35
Gilead Sciences (GILD) United States $84.245B 10.35
CSL (CSLLY) Australia $72.048B 0.00
Celgene (CELG) United States $69.740B 10.79
Vertex Pharmaceuticals (VRTX) United States $44.966B 48.59
Illumina (ILMN) United States $44.234B 51.97
Biogen (BIIB) United States $43.646B 7.75
Regeneron Pharmaceuticals (REGN) United States $30.931B 14.04
Alexion Pharmaceuticals (ALXN) United States $24.082B 12.69
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.438B 48.37
Exact Sciences (EXAS) United States $13.817B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.038B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.422B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.307B 0.00
Galapagos (GLPG) Belgium $8.835B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.614B 52.60
Guardant Health (GH) United States $7.205B 0.00
Sarepta Therapeutics (SRPT) United States $6.393B 0.00
BeiGene (BGNE) Cayman Islands $6.372B 0.00
Amarin (AMRN) Ireland $5.969B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.845B 0.00
Exelixis (EXEL) United States $5.828B 15.15
Bluebird Bio (BLUE) United States $5.795B 0.00
Moderna (MRNA) United States $5.517B 0.00
Horizon Pharma Public (HZNP) Ireland $4.911B 12.48
ARGENX SE-ADR (ARGX) Netherlands $4.760B 0.00
Ascendis Pharma (ASND) Denmark $4.370B 0.00
Repligen (RGEN) United States $4.109B 79.74
Spark Therapeutics (ONCE) United States $4.032B 0.00
China Biologic Products (CBPO) China $3.914B 24.43
Blueprint Medicines (BPMC) United States $3.877B 0.00
Medicines (MDCO) United States $3.790B 0.00
MorphoSys AG (MOR) Germany $3.725B 0.00
Alkermes (ALKS) Ireland $3.504B 0.00
Mirati Therapeutics (MRTX) United States $3.362B 0.00
Immunomedics (IMMU) United States $3.210B 0.00
Emergent Biosolutions (EBS) United States $2.683B 40.31
Genomic Health (GHDX) United States $2.674B 50.15
Reata Pharmaceuticals (RETA) United States $2.607B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.606B 0.00
Arena Pharmaceuticals (ARNA) United States $2.552B 5.48
Ultragenyx Pharmaceutical (RARE) United States $2.544B 0.00
Amicus Therapeutics (FOLD) United States $2.495B 0.00
MyoKardia (MYOK) United States $2.489B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Acceleron Pharma (XLRN) United States $2.313B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.253B 0.00
NeoGenomics (NEO) United States $2.218B 118.67
Myriad Genetics (MYGN) United States $2.025B 21.26
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.973B 0.00
Akcea Therapeutics (AKCA) United States $1.949B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.893B 0.00
Ligand Pharmaceuticals (LGND) United States $1.852B 23.42
Denali Therapeutics (DNLI) United States $1.804B 0.00
UniQure (QURE) Netherlands $1.797B 0.00
Insmed (INSM) United States $1.679B 0.00
Coherus BioSciences (CHRS) United States $1.409B 0.00
REGENXBIO (RGNX) United States $1.396B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.358B 0.00
Alector (ALEC) United States $1.307B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.291B 0.00
Editas Medicine (EDIT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.255B 0.00
RA PHARMCTL INC (RARX) United States $1.208B 0.00
AnaptysBio (ANAB) United States $1.193B 0.00
Fate Therapeutics (FATE) United States $1.172B 0.00
Innoviva (INVA) United States $1.160B 3.35
Epizyme (EPZM) United States $1.089B 0.00
Athenex (ATNX) United States $1.065B 0.00
Zymeworks (ZYME) Canada $1.006B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.999B 0.00
Twist Bioscience (TWST) United States $0.973B 0.00
Cara Therapeutics (CARA) United States $0.933B 0.00
ANI Pharmaceuticals (ANIP) United States $0.926B 15.46
Arvinas (ARVN) United States $0.850B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.841B 0.00
Codexis (CDXS) United States $0.838B 0.00
Principia Biopharma (PRNB) United States $0.834B 435.13
WAVE Life Sciences (WVE) Singapore $0.821B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.769B 0.00
Anika Therapeutics (ANIK) United States $0.743B 26.30
Zealand Pharma (ZEAL) Denmark $0.742B 8.60
Cytokineticsorporated (CYTK) United States $0.727B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.724B 26.14
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Intellia Therapeutics (NTLA) United States $0.696B 0.00
Mesoblast (MESO) Australia $0.681B 0.00
DBV Technologies S.A (DBVT) France $0.618B 0.00
MiMedx (MDXG) United States $0.590B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.549B 0.00
Intra-Cellular Therapies (ITCI) United States $0.548B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.542B 0.00
Cellectis S.A (CLLS) France $0.538B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Retrophin (RTRX) United States $0.523B 0.00
Heska (HSKA) United States $0.523B 67.70
Precision BioSciences (DTIL) United States $0.496B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
UROGEN PHARMA (URGN) United States $0.484B 0.00
Stemline Therapeutics (STML) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.448B 0.00
Puma Biotechnology (PBYI) United States $0.440B 0.00
Arcus Biosciences (RCUS) United States $0.432B 0.00
BioDelivery Sciences (BDSI) United States $0.431B 0.00
Agenus (AGEN) United States $0.417B 0.00
CytomX Therapeutics (CTMX) United States $0.410B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.381B 0.00
Adverum Biotechnologies (ADVM) United States $0.373B 0.00
Scholar Rock Holding (SRRK) United States $0.366B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
AC Immune SA (ACIU) Switzerland $0.341B 25.25
Prothena (PRTA) Ireland $0.336B 0.00
Theratechnologies (THERF) Canada $0.331B 0.00
Albireo Pharma (ALBO) United States $0.317B 0.00
Avid Bioservices (CDMO) United States $0.315B 0.00
Kindred Biosciences (KIN) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.311B 464.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
ADMA Biologics Inc (ADMA) United States $0.303B 0.00
Geron (GERN) United States $0.300B 0.00
Clovis Oncology (CLVS) United States $0.296B 0.00
Prometic Life Sciences (PFSCF) Canada $0.291B 0.00
Dynavax Technologies (DVAX) United States $0.291B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.285B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.265B 0.00
MannKind (MNKD) United States $0.260B 0.00
Inovio Pharmaceuticals (INO) United States $0.256B 0.00
PDL BioPharma (PDLI) United States $0.256B 6.59
Senesco Technologies (ELOX) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
Sutro Biopharma (STRO) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.249B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.246B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.238B 0.00
Athersys (ATHX) United States $0.229B 0.00
Spero Therapeutics (SPRO) United States $0.223B 0.00
Compugen (CGEN) Israel $0.217B 0.00
Kamada (KMDA) Israel $0.212B 8.09
Five Prime Therapeutics (FPRX) United States $0.210B 0.00
Affimed (AFMD) Germany $0.202B 0.00
Cue Biopharma (CUE) United States $0.200B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.198B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.190B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.187B 0.00
Arsanis (XFOR) United States $0.186B 0.00
Acorda Therapeutics (ACOR) United States $0.186B 0.00
Enzo Biochem (ENZ) United States $0.175B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.173B 0.00
Emmaus Life Sciences (EMMA) United States $0.169B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
XOMA (XOMA) United States $0.164B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Northwest Biotherapeutics (NWBO) United States $0.156B 0.00
Strongbridge Biopharma (SBBP) United States $0.155B 6.36
PHASEBIO PHARMA (PHAS) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Alcobra (ARCT) United States $0.151B 0.00
Novavax (NVAX) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Dyadic (DYAI) United States $0.150B 0.00
Abeona Therapeutics (ABEO) United States $0.146B 0.00
Adocia (ADOCY) France $0.140B 0.00
Aptinyx (APTX) United States $0.135B 0.00
NantKwest (NK) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.127B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.108B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Arbutus Biopharma (ABUS) Canada $0.095B 0.00
Idera Pharmaceuticals (IDRA) United States $0.091B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
Trevena (TRVN) United States $0.088B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Selecta Biosciences (SELB) United States $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Catalyst Biosciences (CBIO) United States $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.076B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
VBI Vaccines (VBIV) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Applied Genetic Technologies (AGTC) United States $0.067B 36.80
AquaBounty Technologies (AQB) United States $0.065B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.064B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.044B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.040B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
TOCAGEN INC (TOCA) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00